Founder and Chief Executive Officer
Sanjeev Kr. Chauhan – Founder & CEO of Probgen Biotech India Pvt. Ltd.Dr Arvind Chaudhary
Director, Probgen Biotech India Pvt LTD
Email: arvindchaudhry@probgenbiotech.com
https://www.linkedin.com/in/dr-arvind-chaudhry-53a58758/
Dr Arvind Chaudhry, trained at Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS),
Lucknow, Columbia University Medical Centre (CUMC), New York and Nationwide Children Hospital,
Columbus, Ohio, USA. He has worked with distinguished professionals like Prof T.N. Dhole (Past
president IAMM) (SGPGIMS, Lucknow, Uttar Pradesh), Prof W. Ian Lipkin known as virus hunter
(Columbia University Medical Centre, New York, USA) and Nobel laureate (Prof. Charles Rice). He has
more than 18 years’ experience in molecular diagnostics. Dr Arvind led to develop first next generation
sequencing based test (VIRCAP SEQ) which can detect all known and emerging pathogens in direct
clinical specimens. (https://www.publichealth.columbia.edu/news/diagnostics-breakthrough-brings-
viral-sequencing-doctors-toolkit. He also identified several new viruses including human hepegivirus
(https://www.science.org/content/article/new-human-virus-discovered-old-blood-samples), equine
parvovirus associated with serum hepatitis in horses (https://pubmed.ncbi.nlm.nih.gov/29350162/
Chaudhry also published several papers in international journals including Nature with more than 1000
citations.
With a mission to develop affordable next generation sequencing (NGS) technology, he joined Probgen
biotech, India. Soon, Probgen Biotech is in the process of launching the first made in India test based
on NGS.
Copyright © 2025 https://probgenbiotech.com/ All Rights Reserved.